Proteomics is not only a biomarker discovery tool

Proteomics - Clinical Applications

Volumn 3, Issue 10, 2009, Pages 1136-1139

  Martins de souza, Daniel ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Biomarker; Brain; Neuroscience

Indexed keywords

BIOLOGICAL MARKER; MITOCHONDRIAL ENZYME;

BIPOLAR DISORDER; BRAIN MITOCHONDRION; BRAIN TISSUE; CEREBROSPINAL FLUID ANALYSIS; DEGENERATIVE DISEASE; DEPRESSION; ENERGY METABOLISM; HUMAN; HYDROPHOBICITY; MANIA; MEDICAL RESEARCH; MENTAL DISEASE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; PUBLIC HEALTH; REVIEW; SCHIZOPHRENIA; WELFARE;

EID: 70350762128     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200900096     Document Type: Review

References (24)

1. Wilkins, M. R., Sanchez, J. C., Gooley, A. A., Appel, R. D. et al., Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol. Genet. Eng. Rev. 1996, 13, 19-50.
2. Wilkins, M. R., Pasquali, C., Appel, R. D., Ou, K. et al., From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N Y), 1996, 14, 61-65.
3. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M. et al., Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
4. Freedman, R., Schizophrenia. N. Engl. J. Med. 2003, 349, 1738-1749.
5. Martinowich, K., Schloesser, R. J., Manji, H. K., Bipolar disorder: from genes to behavior pathways. J. Clin. Invest. 2009, 119, 726-736.
6. Compston, A., Coles, A., Multiple sclerosis. Lancet 2002, 359, 1221-1231.
7. Compston, A., Coles, A., Multiple sclerosis. Lancet 2008, 372, 1502-1517.
8. Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., et al., Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 2004, 9, 684-697.
9. Clark, D., Dedova, I., Cordwell, S., Matsumoto, I., A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol. Psychiatry 2006, 11, 459-470.
10. Beasley, C. L., Pennington, K., Behan, A., Wait, R. et al., Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics. 2006, 6, 3414-3425.
11. Sivagnanasundaram, S., Crossett, B., Dedova, I., Cordwell, S., Matsumoto, I., Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study. Proteomics Clin. Appl. 2007, 1, 1291-1305.
12. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G. et al., Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J. Psychiatr. Res. 2009, 43, 978-986.
13. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Novello, J. C. et al., Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 2009, 9, 17.
14. Pennington, K., Beasley, C. L., Dicker, P., Fagan, A. et al., Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol. Psychiatry 2008, 13, 1102-1117.
15. Pennington, K., Dicker, P., Dunn, M. J., Cotter, D. R., Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. Proteomics 2008, 8, 5097-5107.
16. Alexander, J. S., Minagar, A., Harper, M., Robinson-Jackson, S. et al., Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b. J. Mol. Neurosci. 2007, 32, 169-178.
17. Satoh, J., Tabunoki, H., Yamamura, T., Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. Mult. Scler. 2009, 15, 531-541.
18. Hammack, B. N., Fung, K. Y., Hunsucker, S. W., Duncan, M. W. et al., Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult. Scler. 2004, 10, 245-260.
19. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C. et al., Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur. Arch. Psychiatr. Clin. Neurosci. 2009, 259, 151-163.
20. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C. et al., Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J. Neural Transm. 2009, 116, 275-289.
21. Behan, A. T., Byrne, C., Dunn, M. J., Cagney, G., Cotter, D. R., Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol. Psychiatry 2009, 14, 601-613.
22. Gygi, S. P., Corthals, G. L., Zhang, Y., Rochon, Y. et al., Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA. 2000, 97, 9390-9395.
23. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E. et al., Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17, 676-682.
24. Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28, 27-30.